[1]张秀灵,牟春燕,李 武.非生物人工肝支持系统的临床应用现状及进展[J].医学信息,2018,31(02):40-42.[doi:10.3969/j.issn.1006-1959.2018.02.014]
　ZHANG Xiu-ling,MOU Chun-yan,LI Wu.Current Status and Progress of Clinical Application of Abiotic Artificial Liver Support System[J].Journal of Medical Information,2018,31(02):40-42.[doi:10.3969/j.issn.1006-1959.2018.02.014]
点击复制

非生物人工肝支持系统的临床应用现状及进展()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年02期
页码:
40-42
栏目:
综述
出版日期:
2018-01-15

文章信息/Info

Title:
Current Status and Progress of Clinical Application of Abiotic Artificial Liver Support System
文章编号:
1006-1959（2018）02-0040-03
作者:
张秀灵; 牟春燕; 李 武
昆明医科大学第一附属医院感染科，云南 昆明 650032
Author(s):
ZHANG Xiu-ling; MOU Chun-yan; LI Wu
Department of Infectious Diseases,the First Affiliated Hospital of Kunming Medical University,Kunming 650032,Yunnan,China
关键词:
肝衰竭; 非生物型人工肝支持系统; 血浆置换
Keywords:
Key words：Liver failure; Abiotic artificial liver support system; Plasma exchange
分类号:
R318.14
DOI:
10.3969/j.issn.1006-1959.2018.02.014
文献标志码:
A
摘要:
肝衰竭作为临床常见的严重肝病症候群，病死率极高，其治疗包括内科综合治疗、非生物型人工肝支持系统治疗、肝移植和生物干细胞移植等。作为早中期肝衰竭患者过渡到肝移植的重要治疗方法，非生物型人工肝目前已得到国内外的认可与广泛应用。本文重点对常用的非生物型人工肝治疗方式进行综述。
Abstract:
Abstract：As a common clinical syndrome of severe liver disease,liver failure is extremely fatal.Its treatment includes comprehensive medical treatment,non-biological artificial liver support system, liver transplantation and biological stem cell transplantation.As an important treatment for the transition from early liver failure patients to liver transplantation,non-biological artificial liver has now been recognized and widely used at home and abroad.This article focuses on the commonly used non-biological artificial liver treatment are reviewed.

参考文献/References:

[1]唐简,周艳,彭忠田.人工肝血浆置换治疗肝衰竭的临床疗效分析[J].中国现代医学杂志,2011,21(36):4592-4594.
[2]中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝治疗肝衰竭指南(2016年版)[J].中华临床感染病杂志,2016,9(2):97-103.
[3]张爱民,游绍莉,万志红,等.血浆吸附灌流联合血浆置换加用恩替卡韦治疗乙型肝炎相关慢加急性肝衰竭的临床疗效[J].临床肝胆病杂志,2012,28(10):744-747.
[4]YM Wan,YH Li,ZY Xu,et al.Therapeutic plasma exchange versus double plasma molecular ab-sorption system in hepatitis B virus-infected acute-on-chronic liver failure treated by entercavir:A prospective study[J].Journal of Clinical Apheresis,2017,32(6):453-461.
[5]殷桂春,轧春妹,李谦,等.两台血液灌流机组合实现双重血浆分子吸附系统治疗肝衰竭的临床研究[J].中华危重病急救医学,2013,25(12):738-742.
[6]张宝文,阳学风,罗湘俊,等.双重血浆吸附、胆红素吸附及血浆置换治疗肝衰竭的疗效比较[J].中国现代医学杂志,2016,26(12):103-106.
[7]H Ringe,V Varnholt,M Zimmering,et al.Continuous veno-venous single-pass albumin hemodia-filtration in children with acute liver failure[J].Pediatr Crit Care Med,2011,12(3):257-264.
[8]Chan WK,Hui WF.Sequential use of hemoperfusion and single-pass albumin dialysis can safely reverse methotrexate nephrotoxicity[J].Pediatr Nephrol,2016,31(10):1699-1703.
[9]S Frimmel,J Schipper,J Henschel,et al.First description of single-pass albumin dialysis combined with cytokine adsorption in fulminant liver failure and hemophagocytic syndrome resulting from generalized herpes simplex virus 1 infection[J].Liver Transplanta-tion,2015,20(12):1523-1524.
[10]A Vaid,H Chweich,EM Balk,et al.Molecular adsorbent recirculating system as artificial support therapy for liver failure:a meta-analysis[J].Asaio Journal,2012,58(1):51-59.
[11]史晓峰,张玥,张武臣.MARS人工肝系统治疗急性妊娠脂肪肝14例[J].广东医学,2009,30(4):586-587.
[12]A Kribben,G Gerken,S Haag,et al.Effects of fractionated plasma separation and adsorp-tion on survival in patients with acute-on-chronic liver fail-ure[J].Gastroenterology,2012,142(4):782-789.
[13]K Oettl,V Stadlbauer,P Krisper,et al.Effect of extracorporeal liver support by molecu-lar adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure[J].Therapeutic Apheresis&Dialysis,2009,13(5):431-436.

相似文献/References:

[1]李映节,孔宪炳.部分肝切除术后肝功能衰竭的影响因素及术前评估研究[J].医学信息,2019,32(03):37.[doi:10.3969/j.issn.1006-1959.2019.03.013]
　LI Ying-jie,KONG Xian-bing.Influential Factors and Preoperative Evaluation of Liver Failure after Partial Hepatectomy[J].Journal of Medical Information,2019,32(02):37.[doi:10.3969/j.issn.1006-1959.2019.03.013]
[2]杨 洋,李秀惠.HBV 相关慢加急（亚急）性肝衰竭患者血清AFP、CA199临床意义的研究[J].医学信息,2019,32(09):61.[doi:10.3969/j.issn.1006-1959.2019.09.020]
　YANG Yang,LI Xiu-hui.Clinical Significance of Serum AFP and CA199 in Patients with HBV-related Slow-acceleration (Sub-acute) Liver Failure[J].Journal of Medical Information,2019,32(02):61.[doi:10.3969/j.issn.1006-1959.2019.09.020]
[3]吴春城,张满英,梁惠卿,等.论凉血散血法在肝衰竭治疗中的应用[J].医学信息,2020,33(19):160.[doi:10.3969/j.issn.1006-1959.2020.19.051]
[4]郭 婷,王伟新,张丽丽.血浆置换联合分子吸附再循环系统治疗肝衰竭的疗效[J].医学信息,2020,33(24):104.[doi:10.3969/j.issn.1006-1959.2020.24.028]
　GUO Ting,WANG Wei-xin,ZHANG Li-li.The Effect of Plasma Exchange Combined with Molecular Adsorption Recirculation System in the Treatment of Liver Failure[J].Journal of Medical Information,2020,33(02):104.[doi:10.3969/j.issn.1006-1959.2020.24.028]
[5]闫红林,杨永勤,汪 雯,等.老年肝衰竭临床特点及预后转归[J].医学信息,2021,34(05):65.[doi:10.3969/j.issn.1006-1959.2021.05.019]
　YAN Hong-lin,YANG Yong-qin,WANG Wen,et al.Clinical Characteristics and Prognostic Outcome of Elderly Liver Failure[J].Journal of Medical Information,2021,34(02):65.[doi:10.3969/j.issn.1006-1959.2021.05.019]

更新日期/Last Update: 2018-02-15